- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05151107
Residual Gastric Area and Weight Loss After Sleeve Gastrectomy
Relationship Between Residual Gastric Area and Weight Loss After Sleeve Gastrectomy: a Cohort Study
BACKGROUND: The aim of this study is to evaluate the impact of the actual size and area of the remnant stomach, as measured by Upper gastrointestinal tract radiography, on weight loss after LSG.
MATERIALS AND METHODS: From May 2017 to December 2019, 56 patients with morbid obesity were admitted to the Department of Medical and Surgical Sciences, University of Foggia and underwent laparoscopic sleeve gastrectomy.
UGI tract radiography was performed on day two after the operation to rule out leakage.
Study Overview
Status
Conditions
Detailed Description
Study design and setting
From May 2017 to December 2019, 56 patients with morbid obesity were admitted to the Department of Medical and Surgical Sciences, University of Foggia and underwent laparoscopic sleeve gastrectomy. UGI tract radiography with water-soluble contrast medium was performed on the second day after the operation to rule out leakage. The radiographic images were collected through a software program called "PACS" which combined with a viewer for image processing, allows for the calculation of the residual stomach area (RSA). RSA was correlated with postoperative weight (EWL) at 1, 6, and 12 months.
Eligibility criteria
Adult patients of both genders with morbid obesity defined as BMI>40 kg/m2 or BMI>35 kg/m2 with at least one associated major comorbidity were included. We excluded patients with secondary obesity due to endocrine and psychological disorders, patients with previous bariatric procedures and patients unwilling to comply with postoperative diet and exercise program.
Statistical analysis
Continuous data were expressed as mean and standard deviation (SD) and they were analyzed using Student's T test. The correlation between gastric volume before and after LSG and BMI and weight loss was measured using Pearson correlation coefficient test. Correlation coefficients were classified as strong (-1.0 to -0.5 or 0.5 to 1.0), moderate (-0.5 to -0.3 or 0.3 to 0.5), and weak (-0.3 to -0.1 or 0.1 to 0.3). P<0.05 was considered statistically significant. This work is fully compliant with the STROCSS criteria
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Foggia, Italy
- Nicola Tartaglia
-
Foggia, Italy, 71122
- Giovanna Pavone
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adult patients of both genders with morbid obesity defined as BMI>40 kg/m2
- Adult patients of both genders with morbid obesity defined as BMI>35 kg/m2 with at least one associated major comorbidity
Exclusion Criteria:
- Patients with secondary obesity due to endocrine and psychologic disorders
- Patients whit previous bariatric procedures
- Patients unwilling to comply with postoperative diet regimen and exercise program.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative EWL % correlated with the Residual Stomach Area
Time Frame: 2017-2019
|
the impact of the actual size and area of the remnant stomach, as measured by Upper gastrointestinal tract radiography, on weight loss
|
2017-2019
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1 (Other Identifier: Mobile Health and Wellness Program)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity, Morbid
-
ClinTrio Ltd.UnknownMorbid Obesity Requiring Bariatric SurgeryBelgium, Germany, Portugal, Austria, Netherlands, Poland, Saudi Arabia
-
Sohag UniversityActive, not recruitingMorbid Obesity Requiring Bariatric SurgeryEgypt
-
Centre Hospitalier Universitaire de NiceCompletedMorbid Obesity D009765France
-
General Committee of Teaching Hospitals and Institutes...CompletedMorbid Obesity Requiring Bariatric SurgeryEgypt
-
Shanghai Jiao Tong University School of MedicineUnknown
-
Norwegian School of Sport SciencesHjelp24Completed
-
Yongtao SunThe First Hospital affiliated of Shandong First Medical UniversityNot yet recruiting
-
Hospices Civils de LyonCentre de Recherche en Nutrition Humaine Rhone-Alpe; Institut National de Recherche... and other collaboratorsRecruiting
-
Endolumik, IncWest Virginia UniversityNot yet recruitingMorbid ObesityUnited States
-
Laval UniversityInstitut universitaire de cardiologie et de pneumologie de Québec, University...Recruiting